PHARMACYTE BIOTECH, INC. Proceeds from Warrant Exercises
PHARMACYTE BIOTECH, INC. (PMCB) reported Proceeds from Warrant Exercises of $1.05 million for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-07-29
- PHARMACYTE BIOTECH, INC. proceeds from warrant exercises for the quarter ending 2026-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. proceeds from warrant exercises for the quarter ending 2025-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. proceeds from warrant exercises for the quarter ending 2025-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. proceeds from warrant exercises for the quarter ending 2024-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. proceeds from warrant exercises for fiscal 2026 was $1.05M.
- PHARMACYTE BIOTECH, INC. proceeds from warrant exercises for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PHARMACYTE BIOTECH, INC. proceeds from warrant exercises for fiscal 2024 was $70.00, a 92.05% decline from fiscal 2023.
- PHARMACYTE BIOTECH, INC. proceeds from warrant exercises for fiscal 2023 was $880.00.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2026-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $1.05M 10-K · filed 2026-07-29 | ||
| 2026-01-31 | $1.05M 10-Q · filed 2026-03-17 | |||
| 2025-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $0.00 derived: sum of 2 quarters · filed 2026-07-29 | $0.00 derived: sum of 3 quarters · filed 2026-07-29 | $0.00 10-K · filed 2026-07-29 |
| 2025-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $0.00 10-Q · filed 2026-03-17 | $0.00 derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-13 | $0.00 10-Q · filed 2024-12-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-11 | $0.00 derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-07-31 | $0.00 10-Q · filed 2024-09-17 | $0.00 derived: sum of 2 quarters · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2025-08-11 | $0.00 derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | $0.00 derived: sum of 2 quarters · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2025-08-11 | $70.00 10-K · filed 2025-08-11 |
| 2024-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $70.00 10-Q · filed 2025-03-17 | $70.00 derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-13 | $70.00 10-Q · filed 2024-12-13 | $70.00 derived: sum of 3 quarters · filed 2024-12-13 | $70.00 derived: sum of 4 quarters · filed 2024-12-13 |
| 2023-07-31 | $70.00 10-Q · filed 2024-09-17 | $70.00 derived: sum of 2 quarters · filed 2024-09-17 | $70.00 derived: sum of 3 quarters · filed 2024-09-17 | $70.00 derived: sum of 4 quarters · filed 2024-09-17 |
| 2023-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-13 | $0.00 derived: sum of 2 quarters · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2024-08-13 | $880.00 10-K · filed 2024-08-13 |
| 2023-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-18 | $0.00 derived: sum of 2 quarters · filed 2024-03-18 | $880.00 10-Q · filed 2024-03-18 | $880.00 derived: sum of 4 quarters · filed 2024-03-18 |
| 2022-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15 | $880.00 10-Q · filed 2023-12-15 | $880.00 derived: sum of 3 quarters · filed 2023-12-15 | $880.00 derived: sum of 4 quarters · filed 2023-12-15 |
| 2022-07-31 | $880.00 10-Q · filed 2023-09-18 | $880.00 derived: sum of 2 quarters · filed 2023-09-18 | $880.00 derived: sum of 3 quarters · filed 2023-09-18 | |
| 2022-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | $0.00 derived: sum of 2 quarters · filed 2023-07-31 | $0.00 10-K · filed 2023-07-31 | |
| 2022-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | $0.00 10-Q · filed 2023-03-16 | ||
| 2021-10-31 | $0.00 10-Q · filed 2022-12-14 | |||
| 2015-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | $0.00 derived: sum of 2 quarters · filed 2015-03-13 | $1.66M 10-Q · filed 2015-03-13 | |
| 2014-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $1.66M 10-Q · filed 2014-12-15 | ||
| 2014-07-31 | $1.66M 10-Q · filed 2014-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |